UBS OCONNOR LLC - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 98422LAA5. A total of 4 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$3,461,000,000
-10.4%
2,000,0000.0%0.07%
-27.6%
Q3 2020$3,861,000,000
+93.0%
2,000,0000.0%0.10%
+122.7%
Q2 2020$2,000,000,0002,000,0000.04%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
683 Capital Management, LLC 2,950,000$3,038,5000.24%
Saltoro Capital, LP 250,000$243,7500.22%
LAZARD ASSET MANAGEMENT LLC 11,500,000$11,2120.02%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders